等待開盤 11-26 09:30:00 美东时间
+0.180
+3.13%
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock rose 10.2% to $2.8 during Wedn...
11-20 05:07
Enveric Biosciences press release (ENVB): Q3 GAAP EPS of -$10.81. The net loss for the quarter included approximately $0.2 million in non-cash expenses related to stock-based compensation and other no...
11-15 05:49
The latest update is out from Enveric Biosciences ( ($ENVB) ). Enveric Bioscien...
10-24 05:05
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 28, 2025Enveric Biosciences (NASDAQ:ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation neuroplastogenic small
10-23 20:16
AbbVie (NYSE:ABBV) snapped six consecutive sessions of losses on Thursday as the stock ended 0.29% lower at $226.87. Since October 8, the stock has closed in the red every day until October 15, during...
10-17 04:52
EB-003, Enveric's lead product candidate, is protected by a different patent family that includes an issued U.S. patent and pending U.S. and international patents, all of which are separate and distinct from the patent
10-15 20:09
Enveric Biosciences (NASDAQ:ENVB) on Tuesday said that its Board of Directors has authorized the Company’s Capital Markets Committee to explore and negotiate non-binding term sheets for potential Digi...
10-14 21:03
https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-suggests/
10-14 01:28
Enveric Biosciences ( ($ENVB) ) has provided an announcement. On September 17, ...
09-19 05:00